Efficient enzyme‐free isolation of brain‐derived extracellular vesicles
Open Access
- 7 November 2024
- journal article
- research article
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 13 (11)
Abstract
Extracellular vesicles (EVs) have gained significant attention as pathology mediators and potential diagnostic tools for neurodegenerative diseases. However, isolation of brain‐derived EVs (BDEVs) from tissue remains challenging, often involving enzymatic digestion steps that may compromise the integrity of EV proteins and overall functionality. Here, we describe that collagenase digestion, commonly used for BDEV isolation, produces undesired protein cleavage of EV‐associated proteins in brain tissue homogenates and cell‐derived EVs. In order to avoid this effect, we studied the possibility of isolating BDEVs with a reduced amount of collagenase or without any protease. Characterization of the isolated BDEVs from mouse and human samples (both female and male) revealed their characteristic morphology and size distribution with both approaches. However, we show that even minor enzymatic digestion induces ‘artificial’ proteolytic processing in key BDEV markers, such as Flotillin‐1, CD81, and the cellular prion protein (PrP C ), whereas avoiding enzymatic treatment completely preserves their integrity. We found no major differences in mRNA and protein content between non‐enzymatically and enzymatically isolated BDEVs, suggesting that the same BDEV populations are purified with both approaches. Intriguingly, the lack of Golgi marker GM130 signal, often referred to as contamination indicator (or negative marker) in EV preparations, seems to result from enzymatic digestion rather than from its actual absence in BDEV samples. Overall, we show that non‐enzymatic isolation of EVs from brain tissue is possible and avoids artificial pruning of proteins while achieving an overall high BDEV yield and purity. This protocol will help to understand the functions of BDEV and their associated proteins in a near‐physiological setting, thus opening new research approaches.Keywords
All Related Versions
Funding Information
- H2020 Marie Skłodowska-Curie Actions (101030402_EXOSOMES AD)
- Creutzfeldt-Jakob Disease Foundation
- Joachim Herz Stiftung
- Alzheimer Forschung Initiative
- Chinese Government Scholarship (202108080249)
This publication has 102 references indexed in Scilit:
- Neuroprotective role of PrPCagainst kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7–PSD-95 bindingMolecular Biology of the Cell, 2011
- The cellular prion protein mediates neurotoxic signalling of β‐sheet‐rich conformers independent of prion replicationThe EMBO Journal, 2011
- Exosomes – vesicular carriers for intercellular communicationCurrent Opinion in Cell Biology, 2009
- Paracrine Diffusion of PrPC and Propagation of Prion Infectivity by Plasma Membrane-Derived MicrovesiclesPLOS ONE, 2009
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomersNature, 2009
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 2007
- Optimized Flow Cytometric Analysis of Central Nervous System Tissue Reveals Novel Functional Relationships Among Cells Expressing CD133, CD15, and CD24Stem Cells, 2007
- A low temperature method of isolating normal human articular chondrocytesOsteoarthritis and Cartilage, 2006
- Cells release prions in association with exosomesProceedings of the National Academy of Sciences, 2004
- Novel Proteinaceous Infectious Particles Cause ScrapieScience, 1982